Organic sales grew 1.0% year-over-year, with strong performance in Asia, while adjusted operating margin rose to 9.6%. Net income and EPS declined due to restructuring in Türkiye, but record operating cash flow and a lower leverage ratio were achieved. Guidance for 2026 remains unchanged, with continued focus on cost control and shareholder returns.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.